manufacturing Archives - Page 3 of 6 -

News/ News/ Sales and Marketing

Moderna ramps up EU COVID jab capacity via Lonza deal

Phil Taylor coronavirus, COVID-19, COVID-19 vaccine, EU, Lonza, manufacturing, Moderna, Sinovac 0 Comment

Capacity to supply Moderna’s COVID-19 vaccine in Europe could be swelled by around 300 million doses a year,

Moderna ramps up EU COVID jab capacity via Lonza deal

https://pharmaphorum.com/news/moderna-ramps-up-eu-covid-jab-capacity-via-lonza-deal/

Market Access/ News/ News

FDA pens stinging report on Emergent COVID vaccine plant

Phil Taylor AstraZeneca, coronavirus, coronavirus vaccine, COVID-19, Emergent BioSolutions, fda, Johnson & Johnson, manufacturing 0 Comment

Emergent BioSolutions’ difficult month has been made worse by an FDA report into its facility in Baltimore, which

FDA pens stinging report on Emergent COVID vaccine plant

https://pharmaphorum.com/news/fda-pens-stinging-report-on-emergent-covid-vaccine-plant/

Data hackathon analyses truth behind ‘game-changer’ COVID vaccine

R&D/ Views & Analysis/ Views and analysis

COVID-19 underscores need to boost pharma manufacturing in emerging markets

Catherine Longworth COVID-19, emerging markets, manufacturing, vaccines 0 Comment

For the past year, life science companies around the world worked at breakneck speed to develop and manufacture

COVID-19 underscores need to boost pharma manufacturing in emerging markets

https://pharmaphorum.com/views-and-analysis/covid-underscores-need-to-boost-pharma-manufacturing-in-emerging-markets/

News/ News/ Sales and Marketing

Bomb scare sparks evacuation of plant making AZ COVID-19 vaccine

Phil Taylor AstraZeneca, coronavirus, coronavirus vaccine, COVID-19, manufacturing, Wockhardt 0 Comment

A plant in Wales manufacturing the AstraZeneca COVID-19 vaccine was evacuated on the advice of the authorities today

Bomb scare sparks evacuation of plant making AZ COVID-19 vaccine

https://pharmaphorum.com/news/bomb-scare-sparks-evacuation-of-plant-making-az-covid-19-vaccine/

Market Access/ Oncology/ Views & Analysis/ Views & Analysis/ Views and analysis

Why cell therapy manufacture is a team sport

mike.hammerton@pharmaphorum.com cancer, CAR T, cell therapy, EU, Europe, Gilead, Kite, manufacturing 0 Comment

Louis van de Wiel, Vice President, Site Head EU Manufacturing, Kite, a Gilead Company, reveals the complexity that

Why cell therapy manufacture is a team sport

https://pharmaphorum.com/market-access-2/why-cell-therapy-manufacture-is-a-team-sport/

News/ News/ R&D

Pfizer cut vaccine production targets because of raw material shortage – reports

Richard Staines COVID-19, manufacturing, Moderna, Pfizer, vaccine 0 Comment

Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its

Pfizer cut vaccine production targets because of raw material shortage – reports

https://pharmaphorum.com/news/pfizer-cut-vaccine-production-targets-because-of-raw-material-shortage-reports/

Digital/ News/ News

BioNTech, InstaDeep plan joint lab for AI research

Phil Taylor Analytics, Artifical Intellgence, BioNTech, digital, drug discovery, InstaDeep, machine learning, manufacturing, supply chain 0 Comment

BioNTech may be deeply ensconced in the latter stages of its bid to bring a COVID-19 vaccine to

BioNTech, InstaDeep plan joint lab for AI research

https://pharmaphorum.com/news/biontech-instadeep-plan-joint-lab-for-ai-research/

News/ News/ Sales and Marketing

Could an FDA inspection scupper CVR deadline for BMS’ liso-cel?

Phil Taylor Bristol-Myers Squibb, Celgene, fda, liso-cel, manufacturing 0 Comment

Bristol-Myers Squibb posted a solid set of financial results for the third quarter, but shares slid on investor

Could an FDA inspection scupper CVR deadline for BMS’ liso-cel?

https://pharmaphorum.com/news/could-an-fda-inspection-scupper-cvr-deadline-for-bms-liso-cel/

Market Access/ News/ News

Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approved

Phil Taylor BioNTech, coronavirus, coronavirus vaccine, COVID-19, manufacturing, Pfizer 0 Comment

Pfizer now has hundreds of thousands of doses of BioNTech’s COVID-19 vaccine coming off the production line at

Pfizer ‘ready to roll’ if BioNTech COVID-19 shot is approved

https://pharmaphorum.com/news/pfizer-ready-to-roll-if-biontech-covid-19-shot-is-approved/

Trending

manufacturing

Login